FDA Expands Indication for Gilead’s Biktarvy for HIV With Suppressed Viral Loads, Pre-Existing Resistance

Biktarvy approved for expanded indication to include patients with HIV who have suppressed viral loads with known or suspected M184V/I resistance.

Source link
#FDA #Expands #Indication #Gileads #Biktarvy #HIV #Suppressed #Viral #Loads #PreExisting #Resistance